Angiodynamics (ANGO) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$41.6 million.
- Angiodynamics' Enterprise Value rose 2301.95% to -$41.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$41.6 million, marking a year-over-year increase of 2301.95%. This contributed to the annual value of -$55.9 million for FY2025, which is 2651.07% up from last year.
- Angiodynamics' Enterprise Value amounted to -$41.6 million in Q4 2025, which was up 2301.95% from -$38.8 million recorded in Q3 2025.
- Angiodynamics' 5-year Enterprise Value high stood at -$23.9 million for Q1 2022, and its period low was -$78.5 million during Q1 2024.
- Its 5-year average for Enterprise Value is -$45.9 million, with a median of -$44.7 million in 2023.
- Its Enterprise Value has fluctuated over the past 5 years, first soared by 5614.02% in 2022, then plummeted by 16053.93% in 2024.
- Angiodynamics' Enterprise Value (Quarter) stood at -$34.3 million in 2021, then increased by 12.93% to -$29.9 million in 2022, then tumbled by 103.96% to -$60.9 million in 2023, then rose by 11.18% to -$54.1 million in 2024, then rose by 23.02% to -$41.6 million in 2025.
- Its Enterprise Value was -$41.6 million in Q4 2025, compared to -$38.8 million in Q3 2025 and -$55.9 million in Q2 2025.